1 Immune Globulin Intravenous Market Overview 1.1 Product Overview and Scope of Immune Globulin Intravenous 1.2 Immune Globulin Intravenous Segment by Type 1.2.1 Global Immune Globulin Intravenous Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 IVIg Liquid 1.2.3 IVIg Powder 1.3 Immune Globulin Intravenous Segment by Application 1.3.1 Global Immune Globulin Intravenous Sales Comparison by Application: (2021-2027) 1.3.2 Immunodeficiency 1.3.3 Autoimmune Disease 1.3.4 Acute Infection 1.4 Global Immune Globulin Intravenous Market Size Estimates and Forecasts 1.4.1 Global Immune Globulin Intravenous Revenue 2016-2027 1.4.2 Global Immune Globulin Intravenous Sales 2016-2027 1.4.3 Immune Globulin Intravenous Market Size by Region: 2016 Versus 2021 Versus 2027 2 Immune Globulin Intravenous Market Competition by Manufacturers 2.1 Global Immune Globulin Intravenous Sales Market Share by Manufacturers (2016-2021) 2.2 Global Immune Globulin Intravenous Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Immune Globulin Intravenous Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Immune Globulin Intravenous Manufacturing Sites, Area Served, Product Type 2.5 Immune Globulin Intravenous Market Competitive Situation and Trends 2.5.1 Immune Globulin Intravenous Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Immune Globulin Intravenous Players Market Share by Revenue 2.5.3 Global Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Immune Globulin Intravenous Retrospective Market Scenario by Region 3.1 Global Immune Globulin Intravenous Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Immune Globulin Intravenous Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Immune Globulin Intravenous Market Facts & Figures by Country 3.3.1 North America Immune Globulin Intravenous Sales by Country 3.3.2 North America Immune Globulin Intravenous Revenue by Country 3.3.3 the United States 3.3.4 Canada 3.4 Europe Immune Globulin Intravenous Market Facts & Figures by Country 3.4.1 Europe Immune Globulin Intravenous Sales by Country 3.4.2 Europe Immune Globulin Intravenous Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 UK 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Immune Globulin Intravenous Market Facts & Figures by Region 3.5.1 Asia Pacific Immune Globulin Intravenous Sales by Region 3.5.2 Asia Pacific Immune Globulin Intravenous Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Immune Globulin Intravenous Market Facts & Figures by Country 3.6.1 Latin America Immune Globulin Intravenous Sales by Country 3.6.2 Latin America Immune Globulin Intravenous Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Immune Globulin Intravenous Market Facts & Figures by Country 3.7.1 Middle East and Africa Immune Globulin Intravenous Sales by Country 3.7.2 Middle East and Africa Immune Globulin Intravenous Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Immune Globulin Intravenous Historic Market Analysis by Type 4.1 Global Immune Globulin Intravenous Sales Market Share by Type (2016-2021) 4.2 Global Immune Globulin Intravenous Revenue Market Share by Type (2016-2021) 4.3 Global Immune Globulin Intravenous Price by Type (2016-2021) 5 Global Immune Globulin Intravenous Historic Market Analysis by Application 5.1 Global Immune Globulin Intravenous Sales Market Share by Application (2016-2021) 5.2 Global Immune Globulin Intravenous Revenue Market Share by Application (2016-2021) 5.3 Global Immune Globulin Intravenous Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Takeda 6.1.1 Takeda Corporation Information 6.1.2 Takeda Description and Business Overview 6.1.3 Takeda Immune Globulin Intravenous Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Takeda Immune Globulin Intravenous Product Portfolio 6.1.5 Takeda Recent Developments/Updates 6.2 Grifols 6.2.1 Grifols Corporation Information 6.2.2 Grifols Description and Business Overview 6.2.3 Grifols Immune Globulin Intravenous Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Grifols Immune Globulin Intravenous Product Portfolio 6.2.5 Grifols Recent Developments/Updates 6.3 CSL 6.3.1 CSL Corporation Information 6.3.2 CSL Description and Business Overview 6.3.3 CSL Immune Globulin Intravenous Sales, Revenue and Gross Margin (2016-2021) 6.3.4 CSL Immune Globulin Intravenous Product Portfolio 6.3.5 CSL Recent Developments/Updates 6.4 Octapharma 6.4.1 Octapharma Corporation Information 6.4.2 Octapharma Description and Business Overview 6.4.3 Octapharma Immune Globulin Intravenous Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Octapharma Immune Globulin Intravenous Product Portfolio 6.4.5 Octapharma Recent Developments/Updates 6.5 Biotest 6.5.1 Biotest Corporation Information 6.5.2 Biotest Description and Business Overview 6.5.3 Biotest Immune Globulin Intravenous Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Biotest Immune Globulin Intravenous Product Portfolio 6.5.5 Biotest Recent Developments/Updates 6.6 Kedrion 6.6.1 Kedrion Corporation Information 6.6.2 Kedrion Description and Business Overview 6.6.3 Kedrion Immune Globulin Intravenous Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Kedrion Immune Globulin Intravenous Product Portfolio 6.6.5 Kedrion Recent Developments/Updates 6.7 Hualan Bio 6.6.1 Hualan Bio Corporation Information 6.6.2 Hualan Bio Description and Business Overview 6.6.3 Hualan Bio Immune Globulin Intravenous Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Hualan Bio Immune Globulin Intravenous Product Portfolio 6.7.5 Hualan Bio Recent Developments/Updates 6.8 CNBG 6.8.1 CNBG Corporation Information 6.8.2 CNBG Description and Business Overview 6.8.3 CNBG Immune Globulin Intravenous Sales, Revenue and Gross Margin (2016-2021) 6.8.4 CNBG Immune Globulin Intravenous Product Portfolio 6.8.5 CNBG Recent Developments/Updates 6.9 Shanghai RAAS 6.9.1 Shanghai RAAS Corporation Information 6.9.2 Shanghai RAAS Description and Business Overview 6.9.3 Shanghai RAAS Immune Globulin Intravenous Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Shanghai RAAS Immune Globulin Intravenous Product Portfolio 6.9.5 Shanghai RAAS Recent Developments/Updates 6.10 CBPO 6.10.1 CBPO Corporation Information 6.10.2 CBPO Description and Business Overview 6.10.3 CBPO Immune Globulin Intravenous Sales, Revenue and Gross Margin (2016-2021) 6.10.4 CBPO Immune Globulin Intravenous Product Portfolio 6.10.5 CBPO Recent Developments/Updates 6.11 LFB Group 6.11.1 LFB Group Corporation Information 6.11.2 LFB Group Immune Globulin Intravenous Description and Business Overview 6.11.3 LFB Group Immune Globulin Intravenous Sales, Revenue and Gross Margin (2016-2021) 6.11.4 LFB Group Immune Globulin Intravenous Product Portfolio 6.11.5 LFB Group Recent Developments/Updates 6.12 BPL 6.12.1 BPL Corporation Information 6.12.2 BPL Immune Globulin Intravenous Description and Business Overview 6.12.3 BPL Immune Globulin Intravenous Sales, Revenue and Gross Margin (2016-2021) 6.12.4 BPL Immune Globulin Intravenous Product Portfolio 6.12.5 BPL Recent Developments/Updates 6.13 Sichuan Yuanda Shuyang 6.13.1 Sichuan Yuanda Shuyang Corporation Information 6.13.2 Sichuan Yuanda Shuyang Immune Globulin Intravenous Description and Business Overview 6.13.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Portfolio 6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates 7 Immune Globulin Intravenous Manufacturing Cost Analysis 7.1 Immune Globulin Intravenous Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Immune Globulin Intravenous 7.4 Immune Globulin Intravenous Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Immune Globulin Intravenous Distributors List 8.3 Immune Globulin Intravenous Customers 9 Immune Globulin Intravenous Market Dynamics 9.1 Immune Globulin Intravenous Industry Trends 9.2 Immune Globulin Intravenous Growth Drivers 9.3 Immune Globulin Intravenous Market Challenges 9.4 Immune Globulin Intravenous Market Restraints 10 Global Market Forecast 10.1 Immune Globulin Intravenous Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Immune Globulin Intravenous by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Immune Globulin Intravenous by Type (2022-2027) 10.2 Immune Globulin Intravenous Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Immune Globulin Intravenous by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Immune Globulin Intravenous by Application (2022-2027) 10.3 Immune Globulin Intravenous Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Immune Globulin Intravenous by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Immune Globulin Intravenous by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Immune Globulin Intravenous Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Immune Globulin Intravenous Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Immune Globulin Intravenous Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Immune Globulin Intravenous Covered in This Study Table 5. Global Immune Globulin Intravenous Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Immune Globulin Intravenous Sales Market Share by Manufacturers (2016-2021) Table 7. Global Immune Globulin Intravenous Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Immune Globulin Intravenous Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Immune Globulin Intravenous Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Immune Globulin Intravenous Manufacturing Sites and Area Served Table 11. Manufacturers Immune Globulin Intravenous Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Immune Globulin Intravenous by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Globulin Intravenous as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Immune Globulin Intravenous Sales by Region (2016-2021) & (K Units) Table 16. Global Immune Globulin Intravenous Sales Market Share by Region (2016-2021) Table 17. Global Immune Globulin Intravenous Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Immune Globulin Intravenous Sales by Country (2016-2021) & (K Units) Table 19. North America Immune Globulin Intravenous Sales Market Share by Country (2016-2021) Table 20. North America Immune Globulin Intravenous Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Immune Globulin Intravenous Revenue Market Share by Country (2016-2021) Table 22. Europe Immune Globulin Intravenous Sales by Country (2016-2021) & (K Units) Table 23. Europe Immune Globulin Intravenous Sales Market Share by Country (2016-2021) Table 24. Europe Immune Globulin Intravenous Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Immune Globulin Intravenous Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Immune Globulin Intravenous Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Immune Globulin Intravenous Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Immune Globulin Intravenous Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Immune Globulin Intravenous Revenue Market Share by Region (2016-2021) Table 30. Latin America Immune Globulin Intravenous Sales by Country (2016-2021) & (K Units) Table 31. Latin America Immune Globulin Intravenous Sales Market Share by Country (2016-2021) Table 32. Latin America Immune Globulin Intravenous Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Immune Globulin Intravenous Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Immune Globulin Intravenous Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Immune Globulin Intravenous Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Immune Globulin Intravenous Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Immune Globulin Intravenous Revenue Market Share by Country (2016-2021) Table 38. Global Immune Globulin Intravenous Sales (K Units) by Type (2016-2021) Table 39. Global Immune Globulin Intravenous Sales Market Share by Type (2016-2021) Table 40. Global Immune Globulin Intravenous Revenue (Million US$) by Type (2016-2021) Table 41. Global Immune Globulin Intravenous Revenue Share by Type (2016-2021) Table 42. Global Immune Globulin Intravenous Price (USD/Unit) by Type (2016-2021) Table 43. Global Immune Globulin Intravenous Sales (K Units) by Application (2016-2021) Table 44. Global Immune Globulin Intravenous Sales Market Share by Application (2016-2021) Table 45. Global Immune Globulin Intravenous Revenue (Million US$) by Application (2016-2021) Table 46. Global Immune Globulin Intravenous Revenue Share by Application (2016-2021) Table 47. Global Immune Globulin Intravenous Price (USD/Unit) by Application (2016-2021) Table 48. Takeda Corporation Information Table 49. Takeda Description and Business Overview Table 50. Takeda Immune Globulin Intravenous Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Takeda Immune Globulin Intravenous Product Table 52. Takeda Recent Developments/Updates Table 53. Grifols Corporation Information Table 54. Grifols Description and Business Overview Table 55. Grifols Immune Globulin Intravenous Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Grifols Immune Globulin Intravenous Product Table 57. Grifols Recent Developments/Updates Table 58. CSL Corporation Information Table 59. CSL Description and Business Overview Table 60. CSL Immune Globulin Intravenous Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. CSL Immune Globulin Intravenous Product Table 62. CSL Recent Developments/Updates Table 63. Octapharma Corporation Information Table 64. Octapharma Description and Business Overview Table 65. Octapharma Immune Globulin Intravenous Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Octapharma Immune Globulin Intravenous Product Table 67. Octapharma Recent Developments/Updates Table 68. Biotest Corporation Information Table 69. Biotest Description and Business Overview Table 70. Biotest Immune Globulin Intravenous Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Biotest Immune Globulin Intravenous Product Table 72. Biotest Recent Developments/Updates Table 73. Kedrion Corporation Information Table 74. Kedrion Description and Business Overview Table 75. Kedrion Immune Globulin Intravenous Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Kedrion Immune Globulin Intravenous Product Table 77. Kedrion Recent Developments/Updates Table 78. Hualan Bio Corporation Information Table 79. Hualan Bio Description and Business Overview Table 80. Hualan Bio Immune Globulin Intravenous Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Hualan Bio Immune Globulin Intravenous Product Table 82. Hualan Bio Recent Developments/Updates Table 83. CNBG Corporation Information Table 84. CNBG Description and Business Overview Table 85. CNBG Immune Globulin Intravenous Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. CNBG Immune Globulin Intravenous Product Table 87. CNBG Recent Developments/Updates Table 88. Shanghai RAAS Corporation Information Table 89. Shanghai RAAS Description and Business Overview Table 90. Shanghai RAAS Immune Globulin Intravenous Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Shanghai RAAS Immune Globulin Intravenous Product Table 92. Shanghai RAAS Recent Developments/Updates Table 93. CBPO Corporation Information Table 94. CBPO Description and Business Overview Table 95. CBPO Immune Globulin Intravenous Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. CBPO Immune Globulin Intravenous Product Table 97. CBPO Recent Developments/Updates Table 98. LFB Group Corporation Information Table 99. LFB Group Description and Business Overview Table 100. LFB Group Immune Globulin Intravenous Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. LFB Group Immune Globulin Intravenous Product Table 102. LFB Group Recent Developments/Updates Table 103. BPL Corporation Information Table 104. BPL Description and Business Overview Table 105. BPL Immune Globulin Intravenous Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. BPL Immune Globulin Intravenous Product Table 107. BPL Recent Developments/Updates Table 108. Sichuan Yuanda Shuyang Corporation Information Table 109. Sichuan Yuanda Shuyang Description and Business Overview Table 110. Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 111. Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Table 112. Sichuan Yuanda Shuyang Recent Developments/Updates Table 113. Production Base and Market Concentration Rate of Raw Material Table 114. Key Suppliers of Raw Materials Table 115. Immune Globulin Intravenous Distributors List Table 116. Immune Globulin Intravenous Customers List Table 117. Immune Globulin Intravenous Market Trends Table 118. Immune Globulin Intravenous Growth Drivers Table 119. Immune Globulin Intravenous Market Challenges Table 120. Immune Globulin Intravenous Market Restraints Table 121. Global Immune Globulin Intravenous Sales Forecast by Type (2022-2027) & (K Units) Table 122. Global Immune Globulin Intravenous Sales Market Share Forecast by Type (2022-2027) Table 123. Global Immune Globulin Intravenous Revenue Forecast by Type (2022-2027) & (US$ Million) Table 124. Global Immune Globulin Intravenous Revenue Market Share Forecast by Type (2022-2027) Table 125. Global Immune Globulin Intravenous Sales Forecast by Application (2022-2027) & (K Units) Table 126. Global Immune Globulin Intravenous Sales Market Share Forecast by Application (2022-2027) Table 127. Global Immune Globulin Intravenous Revenue Forecast by Application (2022-2027) & (US$ Million) Table 128. Global Immune Globulin Intravenous Revenue Market Share Forecast by Application (2022-2027) Table 129. Global Immune Globulin Intravenous Sales Forecast by Region (2022-2027) & (K Units) Table 130. Global Immune Globulin Intravenous Sales Market Share Forecast by Region (2022-2027) Table 131. Global Immune Globulin Intravenous Revenue Forecast by Region (2022-2027) & (US$ Million) Table 132. Global Immune Globulin Intravenous Revenue Market Share Forecast by Region (2022-2027) Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Immune Globulin Intravenous Figure 2. Global Immune Globulin Intravenous Market Share by Type in 2020 & 2027 Figure 3. IVIg Liquid Product Picture Figure 4. IVIg Powder Product Picture Figure 5. Global Immune Globulin Intravenous Market Share by Application in 2020 & 2027 Figure 6. Immunodeficiency Figure 7. Autoimmune Disease Figure 8. Acute Infection Figure 9. Global Immune Globulin Intravenous Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Immune Globulin Intravenous Market Size 2016-2027 (US$ Million) Figure 11. Global Immune Globulin Intravenous Sales 2016-2027 (K Units) Figure 12. Global Immune Globulin Intravenous Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Immune Globulin Intravenous Sales Share by Manufacturers in 2020 Figure 14. Global Immune Globulin Intravenous Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Immune Globulin Intravenous Players: Market Share by Revenue in 2020 Figure 16. Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Immune Globulin Intravenous Sales Market Share by Region (2016-2021) Figure 18. Global Immune Globulin Intravenous Sales Market Share by Region in 2020 Figure 19. Global Immune Globulin Intravenous Revenue Market Share by Region (2016-2021) Figure 20. Global Immune Globulin Intravenous Revenue Market Share by Region in 2020 Figure 21. the United States Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. UK Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. China Taiwan Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Mexico Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Brazil Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Argentina Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Turkey Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Saudi Arabia Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. UAE Immune Globulin Intravenous Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Sales Market Share of Immune Globulin Intravenous by Type (2016-2021) Figure 44. Sales Market Share of Immune Globulin Intravenous by Application (2016-2021) Figure 45. Sales Market Share of Immune Globulin Intravenous by Application in 2020 Figure 46. Revenue Share of Immune Globulin Intravenous by Application (2016-2021) Figure 47. Revenue Share of Immune Globulin Intravenous by Application in 2020 Figure 48. Manufacturing Cost Structure of Immune Globulin Intravenous Figure 49. Manufacturing Process Analysis of Immune Globulin Intravenous Figure 50. Immune Globulin Intravenous Industrial Chain Analysis Figure 51. Channels of Distribution Figure 52. Distributors Profiles Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Takeda Grifols CSL Octapharma Biotest Kedrion Hualan Bio CNBG Shanghai RAAS CBPO LFB Group BPL Sichuan Yuanda Shuyang